SGLT2 inhibitor reduces atrial tachyarrhythmia recurrence post-cryoballoon ablation: a prospective observational cohort study in patients with and without diabetes
Zheng Chen, Lijing Zhang, Fu Chen, Zhonglin Han, Wei Xu
Springer Nature ·
2025-08-26
· DOI 10.1186/s12872-025-05078-9
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Zheng Chen, Lijing Zhang, Fu Chen, Zhonglin Han, Wei Xu. SGLT2 inhibitor reduces atrial tachyarrhythmia recurrence post-cryoballoon ablation: a prospective observational cohort study in patients with and without diabetes. // BMC Cardiovascular Disorders. – 2025. – DOI: 10.1186/s12872-025-05078-9. – URL: https://doi.org/10.1186/s12872-025-05078-9
Zheng Chen, Lijing Zhang, Fu Chen, Zhonglin Han, & Wei Xu (2025). SGLT2 inhibitor reduces atrial tachyarrhythmia recurrence post-cryoballoon ablation: a prospective observational cohort study in patients with and without diabetes. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-025-05078-9
Zheng Chen, et al. “SGLT2 inhibitor reduces atrial tachyarrhythmia recurrence post-cryoballoon ablation: a prospective observational cohort study in patients with and without diabetes.” BMC Cardiovascular Disorders, 2025. doi:10.1186/s12872-025-05078-9.
@article{Chen2025,
title = {SGLT2 inhibitor reduces atrial tachyarrhythmia recurrence post-cryoballoon ablation: a prospective observational cohort study in patients with and without diabetes},
author = {Chen, Zheng and Zhang, Lijing and Chen, Fu and Han, Zhonglin and Xu, Wei},
journal = {BMC Cardiovascular Disorders},
year = {2025},
doi = {10.1186/s12872-025-05078-9},
url = {https://doi.org/10.1186/s12872-025-05078-9}
}